Dose Related Effects of Radial Extracorporeal Shock Wave Therapy on Upper Trapezius Trigger Points in Patients With Cervicogenic Headache.
NCT ID: NCT06879418
Last Updated: 2025-11-18
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
135 participants
INTERVENTIONAL
2025-03-01
2025-09-15
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Group (B) will receive 2000 shock waves at frequency 10 MHz and 0.18 mj/mm2 energy flux density plus strengthening and stretching exercise for upper trapezius muscle.
Group (C) will receive sham shock wave therapy plus strengthening and stretching exercise for upper trapezius muscle.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effect of Shock Wave Therapy on Upper Trapezius Trigger Points in Patients With Cervicogenic Headache.
NCT05939583
Myoelectric Activity of Upper Trapezius Trigger Point
NCT04778462
Effect of Shock Wave Therapy on Myofascial Pain Syndrome in Adolescent Athletes
NCT06845475
The Effectiveness of Radial ESWT on Upper Trapezius Mtrps
NCT05187468
Interferential Current And Trapezius Myofascial Trigger Points
NCT05275634
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
QUADRUPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Group A
Low dose shock wave therapy plus strengthening and stretching exercise.
Low dose shock wave therapy plus strengthening and stretching exercise for upper trapezius
Patients will receive 2000 shocks, 1 bar (energy flux density 0.045 mj/mm2) at frequency 10 MHz on upper trapezius trigger points plus strengthening and stretching exercises for upper trapezius.
Group B
Medium dose shock wave therapy on upper trapezius trigger points plus strengthening and stretching exercise for upper trapezius
Medium dose shock wave therapy plus strengthening and stretching exercise for upper trapezius
patients will receive 2000 shock with 4 bars (Energy flux density 0.18 mj/mm2) at frequency 10 MHz on upper trapezius trigger points plus strengthening and stretching for upper trapezius
Group C
Sham shock wave therapy plus strengthening and stretching exercises
sham shock wave therapy plus strengthening and stretching exercise for upper trapezius
patients will receive 2000 shock with energy flus density 0.00 on upper trapezius trigger points plus strengthening and stretching exercise for upper trapezius.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Low dose shock wave therapy plus strengthening and stretching exercise for upper trapezius
Patients will receive 2000 shocks, 1 bar (energy flux density 0.045 mj/mm2) at frequency 10 MHz on upper trapezius trigger points plus strengthening and stretching exercises for upper trapezius.
Medium dose shock wave therapy plus strengthening and stretching exercise for upper trapezius
patients will receive 2000 shock with 4 bars (Energy flux density 0.18 mj/mm2) at frequency 10 MHz on upper trapezius trigger points plus strengthening and stretching for upper trapezius
sham shock wave therapy plus strengthening and stretching exercise for upper trapezius
patients will receive 2000 shock with energy flus density 0.00 on upper trapezius trigger points plus strengthening and stretching exercise for upper trapezius.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Skeletal muscle with a palpable taut band
* Hypersensitive point inside the taut band with the ability to reproduce referred pain when the sensitive spot is palpated,
* Joint soreness in at least one of the upper cervical spine's joints (c1-c3)
* Unilateral discomfort that originates in the neck and radiates to the frontotemporal area
* Pain that is made worse by moving the neck
* Headaches that occur at least once a week for a duration longer than three months.
Exclusion Criteria
* Bilateral headaches,
* Other defined cervical problem such as fracture, dislocation, skin disease, illness that is inflammatory, neural illness, vertebrobasilar insufficiency, a birth defect, tumor, or infection.
40 Years
60 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
MTI University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Radwa Fayek Hammam
Lecturer of Basic Science, Faculty of Physical Therapy, MTI University.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Modern University for Technology and Information
Cairo, , Egypt
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
P.T.REC/012/005500
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.